首页> 美国卫生研究院文献>Molecular and Clinical Oncology >Free-B-Ring flavonoids as potential lead compounds for colon cancer therapy
【2h】

Free-B-Ring flavonoids as potential lead compounds for colon cancer therapy

机译:游离B环类黄酮作为结肠癌治疗的潜在先导化合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although flavonoids have been identified as a versatile source of anticancer agents, to the best of our knowledge, no study has yet investigated their anticolon cancer activity in depth. Therefore, the aim of this study was to investigate the association between the structural characteristics of flavonoids and their anticolon cancer activity in the Caco-2 human colon cancer cell line. Our findings demonstrated that the hydroxylation of C5 and C7 in ring A significantly enhanced the anticolon cancer activity of flavonoids over that of 5-fluorouracil, the classic reference cytotoxic agent. By contrast, the glycosylation or the presence of hydroxyl groups in ring B significantly decreased flavonoid anticancer activity. Collectively, these findings suggest a novel, rational design of flavonoid-related compounds that may improve the treatment of colorectal cancer.
机译:尽管黄酮类化合物已被确定为抗癌剂的多用途来源,但据我们所知,尚无深入研究其抗结肠癌活性的研究。因此,本研究的目的是研究Caco-2人结肠癌细胞系中类黄酮的结构特征与其抗结肠癌活性之间的关系。我们的发现表明,与经典的参考细胞毒药物5-氟尿嘧啶相比,A环中C5和C7的羟基化显着增强了类黄酮的抗结肠癌活性。相反,B环中的糖基化或羟基的存在显着降低了类黄酮的抗癌活性。总的来说,这些发现表明类黄酮相关化合物的新颖,合理的设计可以改善大肠癌的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号